Detection and quantification of a focal fat deposition in a liver undergoing multiple operations for neuroendocrine tumor disease using attenuation imaging: a case report

• Published in: Journal of medical case reports 2023-01, Vol.17 (1), p.16-16, Article 16
• Main Authors: Miller, Elisabeth, Kratzer, Wolfgang, Kestler, Angelika
• Format: Article
• Language: English
• Subjects: Attenuation imaging; Case Report; Chromogranin A; Diagnostic imaging; Endocrine System Diseases; Female; Focal fat deposition; Humans; Liver; Liver Neoplasms - diagnostic imaging; Liver Neoplasms - surgery; Medical research; Medicine, Experimental; Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neuroendocrine tumor; Neuroendocrine Tumors - diagnostic imaging; Neuroendocrine Tumors - surgery; Pancreaticoduodenectomy; Ultrasound imaging
• ISSN: 1752-1947; 1752-1947
• DOI: 10.1186/s13256-022-03723-x

In patients with history of malignancy, new-onset liver lesions often present diagnostic challenges. We present the case of a patient with history of neuroendocrine tumor and new-onset echo-rich hepatic lesion, in whom attenuation imaging helped to make the diagnosis. Attenuation imaging is an ultrasound-based technique that allows for the quantification of hepatic fat content on the basis of a measurement of sound attenuation. We present the case of a 62-year-old Caucasian female patient who underwent pylorus-preserving pancreaticoduodenectomy Whipple surgery in 2004 for histologically well-differentiated neuroendocrine tumor with a proliferation rate of 3% of the pancreatic head. During the course, single liver metastases were resected in 2009, 2010, and 2013. In 2019, hemihepatectomy was performed when two liver metastases recurred. The liver metastases each showed a proliferation rate of 10% with vigorous expression of chromogranin A, synaptophysin, and somatostatin. The most recent follow-up examinations showed a normal chromogranin A value and the patient reported a good general condition. However, sonography revealed a blurred, echoic lesion in the liver. On contrast-enhanced sonography, the lesion showed identical behavior to the surrounding liver parenchyma. In the asymptomatic patient, liver biopsy did not seem to be indicated at the current time. Measurement of the attenuation coefficient by attenuation imaging showed a significantly higher measurement in the area of the echo-rich lesion than in the rest of the liver. The overall findings are consistent with focal fat deposition. Attenuation imaging appears to be useful in the evaluation of unclear echo-rich liver lesions. In particular, primary non-malignant-appearing liver lesions that are unremarkable on abdominal contrast-enhanced ultrasound can be more accurately assessed.